Skip to content

Differences in cerebral structure among patients with amnestic mild cognitive impairment and patients with Alzheimer’s disease Running head: Cerebral structure and cognitive impairment

Research on diagnosis and treatment of Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092593
Enrollment
Unknown
Registered
2024-11-19
Start date
2020-01-06
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s disease

Interventions

AD:1. Save medical history, diagnosis and other information
Biological samples and data such as whole blood, plasma, RNA and brain image are stored according to ADNI standard procedures. 2. Using single-cell sequencing method, transcriptome analysis and DNA e
MCI:1. Save medical history, diagnosis and other information
control group:1. Save medical history, diagnosis and other information

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with clinically diagnosed Alzheimer's disease; Patients with cognitive function assessment with decline.

Exclusion criteria

Exclusion criteria: Patients with other cognitive impairment diseases; Patients with Alzheimer's disease secondary to other diseases; Patients with hearing and understanding disorders; Patients with severe organic diseases such as massive stroke, severe liver and kidney dysfunction, severe coronary heart disease and other life-threatening diseases; Patients with persistent speech disorders before admission that pose obstacles to cognitive function assessment; Patients and their families who provide unreliable medical history; Patients with a history of severe brain tumors and brain surgery or long-term residence in other places.

Design outcomes

Primary

MeasureTime frame
Transcriptome analysis;DNA epigenetic modification analysis;Aß and other proteins analysis;brain volume;brain neural activity;protein deposition changes;

Countries

China

Contacts

Public ContactZou liangyu

Department of Neurology, Shenzhen People’s Hospital (First Affiliated Hospital of Southern University of Science and Technology), Second Clinical College, Jinan University

2413258252@qq.com+86 136 6220 5122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026